/Insulet%20Corporation%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Insulet has outperformed the Dow recently, and analysts remain strongly optimistic about the stock’s prospects.
This Nuvation Bio board member and longtime biotech industry insider carried out his first purchase since his appointment in January.
The S&P 500 Index ($SPX ) (SPY ) today is up by +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.41%. Stocks today recovered...
The S&P 500 Index ($SPX ) (SPY ) today is down by -0.36%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.41%. Stocks today are...
Flat revenue growth might be in store for the company in a very crucial market.
/Insulet%20Corporation%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Insulet has outperformed the Nasdaq Composite over the past year and analysts remain strongly bullish about the stock’s prospects.
Tandem Diabetes TNDM is gaining from continued product innovations. Yet, ongoing macroeconomic challenges and tough competition pose challenges. The stock carries a Zacks Rank #3 (Hold) currently.Factors...
At a stroke, it's got a product authorized for a specific use in 27 countries.
Someone's gotta make 'em, and someone's gotta buy 'em.
Tandem Diabetes stock is showing great growth -- but miserable profits.